Mill Creek Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,705
| Closed | -$287K | – | 264 |
|
|
2025
Q1 | $287K | Sell |
4,705
-1,236
| -21% | -$75.4K | 0.01% | 219 |
|
|
2024
Q4 | $336K | Sell |
5,941
-93
| -2% | -$5.26K | 0.01% | 202 |
|
|
2024
Q3 | $312K | Sell |
6,034
-9,989
| -62% | -$517K | 0.01% | 202 |
|
|
2024
Q2 | $665K | Buy |
16,023
+464
| +3% | +$19.3K | 0.02% | 147 |
|
|
2024
Q1 | $844K | Buy |
15,559
+517
| +3% | +$28K | 0.02% | 116 |
|
|
2023
Q4 | $772K | Sell |
15,042
-191
| -1% | -$9.8K | 0.02% | 121 |
|
|
2023
Q3 | $884K | Sell |
15,233
-1,701
| -10% | -$98.7K | 0.03% | 102 |
|
|
2023
Q2 | $1.08M | Buy |
16,934
+755
| +5% | +$48.3K | 0.04% | 96 |
|
|
2023
Q1 | $1.12M | Sell |
16,179
-32
| -0.2% | -$2.22K | 0.04% | 97 |
|
|
2022
Q4 | $1.17M | Buy |
+16,211
| New | +$1.17M | 0.05% | 87 |
|